CVS CVS

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UnitedHealth Acquires Catamaran, Creating a Top-Tier PBM

      Headlines

      Mon, 30 Mar 2015

      process approximately 1 billion prescription claims annually and become the third-largest PBM in the nation following CVS CVS (1.1 billion annual claims) and Express Scripts ESRX (1.3 billion annual claims). After analyzing the deal, we

    2. UnitedHealth Acquires Catamaran, Creating a Top-Tier PBM; We Believe It's a Positive Transaction

      Commentary

      Mon, 30 Mar 2015

      will process approximately 1 billion prescription claims annually and become the third-largest PBM in the nation following CVS (1.1 billion annual claims) and Express Scripts (1.3 billion annual claims). After analyzing the deal, we don't plan

    3. From Barron’s, March 23, 2015 (Part 1)

      Commentary

      Sat, 21 Mar 2015

      BUD, BRK-A/B, AAPL, HON, JPM, BLK, NFLX, DIS, NVS, M, Tencents/700.hk/TCEHY, FCA.it/FCAU, GILD, CVS , TJX, RYA.ir/RYAAY, GOOGL, UA, HDB, REGN, SBUX, FDX, SoftBank/9984.ja/SFTBY, ICE, ABT, Fast Retailing

    4. 5 Cash-Heavy Funds for the Cautious Investor

      Headlines

      Tue, 3 Mar 2015

      approaches investing. The fund's top holdings are more conventional value plays such as Microsoft MSFT, Oracle ORCL, CVS Health CVS , and Aon AON. Wally Weitz lives in Omaha, Nebraska, and he tries to invest like fellow Omahan Warren Buffett

    5. UPDATE 2- CVS urges cost controls for new cholesterol drugs

      Headlines

      Tue, 17 Feb 2015

      Feb 17 (Reuters) - CVS Health warned on Tuesday that the costs of a potent new class of cholesterol treatments could eclipse those of other expensive medicines and overwhelm the U.S. healthcare system "if rigid cost control mechanisms are not put in place."

    6. CORRECTED-UPDATE 1- CVS urges cost controls for new cholesterol, specialty drugs

      Headlines

      Tue, 17 Feb 2015

      Feb 17 (Reuters) - CVS Health on Tuesday warned that costs of a potent new class of cholesterol treatments and other specialty drugs in development could

    7. CVS says new cholesterol drugs could cost U.S. $150 bln/year

      Headlines

      Tue, 17 Feb 2015

      Feb 17 (Reuters) - CVS Health Corp, the second-largest U.S. pharmacy chain operator, has warned that a new class of drugs being developed to lower "bad" cholesterol could cost the U.S. healthcare system as much as $150 billion per year.

    8. Mixed 4Q for CVS as Solid Top-Line Growth Is Again Offset by Profit Headwinds

      Commentary

      Tue, 10 Feb 2015

      CVS reported another mixed quarter; however, these results ..... removal of tobacco products). However, we believe CVS has also priced its pharmacy benefit management products ..... our perspective, much of this lost business was won by CVS .

    9. Cardinal Reports Mixed Fiscal 2Q, Growth Remain Strong but Profits Pressured

      Commentary

      Thu, 29 Jan 2015

      operating margins compress 19 basis points to 2.14%. While the firm did benefit from its generic sourcing partnership with CVS , it faced continued underperformance from its Canadian operations and a revenue shift toward lower-margin product mix. We

    10. McGregor: Oakmark Equity and Income Fund: Fourth Quarter 2014

      Headlines

      Thu, 15 Jan 2015

      return to the Lipper Index is 7%. Oracle, CVS Health, UnitedHealth Group, TE Connectivity ..... Dynamics (sold), United Health Group, CVS Health, Union Pacific and Oracle. Loser ..... 31/14, Oracle represented 3.9%, CVS Health 2.7%, UnitedHealth Group, Inc

    « Prev12345Next »
    Content Partners